Titlebook: Nuclear Medicine in Psychiatry; Andreas Otte,Kurt Audenaert,Rudi A. Dierckx Book 2004 Springer-Verlag Berlin Heidelberg 2004 Alzheimer.Par

漫不经心

Functional Brain Imaging and Drug Development is unknown; second, most psychiatric diseases are exclusively human; and third, animal models are often limited or nonexistent. Usually large multicentric clinical trials are required to demonstrate clinical efficacy of a drug, with large investments and time needed. Functional brain imaging may he

subacute

STALE

Functional Brain Imaging and Large Animal Research neuropsychiatric disorders and explore treatment options. In general, smaller laboratory animals such as mice and rats have been extensively used. Nevertheless, the utilization of larger animals has definite advantages because of their larger brain size, omitting the need for dedicated equipment (m

水獭

宫殿般

Functional Psychopathology: A Diagnostic Approach to Enhance the Return of Human Brain and Behaviournderpinnings of abnormal mental phenomena precise definition of those phenomena is essential. It is hard to imagine that diagnostic constructs of substantial heterogeneity and unproven validity will turn out to have a definable pathophysiology. But that is just what the nosological constructs that p

Iatrogenic

Nuclear Neuroimaging in Child Psychiatryted with submitting children to experimental studies involving ionizing radiation. The progress in nuclear imaging in child psychiatry is dependent on the progress accomplished in adults and the availability of specific treatments for specific disorders. A better understanding of neuroimaging findin

DENT

β-Amyloid Imaging In Vivo and Its Possible Implications for Alzheimer’s Diseasemising therapeutic strategies are being developed directed at various steps in the Aβ biochemical cascade, resulting in reduction of accumulated Aβ. Promising radiotracers such as [.F]FDDNP, [.C]PIB and [.C]SB-13 have been developed for PET imaging of cerebral Aβ accumulation in vivo. The combinatio

补角

Merited

Isometric